
Bioorganic and Medicinal Chemistry Letters p. 1941 - 1946 (1996)
Update date:2022-08-05
Topics:
Mehrotra, Mukund M.
Sternbach, Daniel D.
Rodriguez, Marc
Charifson, Paul
Berman, Judd
The phosphopeptide 1 is a potent inhibitor of pp60(c-src) SH2 domain mediated phosphoprotein interactions (IC50 ≤ 0.5 μM), but lacks cell permeability. The syntheses of its less charged analogs 2 and 3 are described, in which the arginine-binding phosphate group has been substituted with uncharged α-dicarbonyl moieties. The chemistry described here may be of general use for the synthesis of other α-dicarbonyl compounds.
View MoreZhejiang Haizhou Pharmaceutical Co., Ltd.
website:https://www.haizhoupharma.com/
Contact:+86-576-88221016
Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Contact:0086-29-89196322
Address:North of the Fifth Keji Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
Contact:86-931-8272767
Address:Room 602, No.461, Nanchang Road, Chengguan District, Lanzhou City, China PRC
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
website:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
Doi:10.1016/S0040-4020(01)85085-7
(1994)Doi:10.1055/s-0031-1290067
(2012)Doi:10.1080/14756366.2019.1634704
(2019)Doi:10.1021/om101194f
(2011)Doi:10.1021/om5005594
(2014)Doi:10.1021/ja00170a045
(1990)